VECATORIR
TOES
LABOR
Epstein Barr Virus (Latent Membrane Protein) VP-E609
Antibody to Cat. No.
Product Specifications
Description: Applications:
Epstein Barr Virus (LMP) mouse monoclonal antibody
Immunohistochemistry
Immunoglobulin class: All clones: IgG1 Paraffin sections: Trypsin digestion recommended.
Frozen sections: Yes
Clone: CS1, CS2, CS3 and CS4.
Working Dilution*: 1:100 - 1:200 for 1hr at 25 掳C.
Positive Control: Lymph node, Hodgkin鈥檚 disease
Immunogen: Fusion protein including sequences of
(about 50% of cases are likely to
the EBV encoded latent membrane protein (LMP-1) and
be positive). Cytoplasmic staining
bacterial beta-galactosidase.
pattern may be observed in Reed
Sternberg cells.
Epitope: Not determined. Each clone binds within the
hydrophilic C-terminus of the cytoplasmic domain of Western blotting: Not recommended.
LMP-1.
* Recommended dilutions using VECTASTAIN庐 Elite庐
Presentation: Lyophilized tissue culture supernatant ABC Kits.
containing 15mM sodium azide. Reconstitute with 1 ml
of distilled water. Functional Aspects:
This pool of four monoclonal antibodies detects the
Storage Conditions: latent membrane protein (LMP-1) derived from the
Keep unopened vial at 2 - 8 掳C for 1 year. Once opened BNLF1 gene of Epstein-Barr virus (EBV). This antibody
it is recommended that reconstituted stock solution be cocktail will help detect EBV infected cells in normal
aliquoted and quick frozen and stored at -20 掳C. Do not and uncharacterized tissues.
repeatedly freeze/thaw.
Selected References
Murray P G, Young L S, Rowe M, et al.. Immunohistochemical demonstration of the Epstein-Barr virus-encoded latent membrane protein in paraffin
sections of Hodgkin鈥檚 disease. Journal of Pathology. 166: 1-5 (1992).
Herbst H, Dallenbach F, Hummel M, et al.. Epstein-Barr virus DNA and latent gene products in Ki-1 (CD30)-positive anaplastic large cell lymphoma.
Blood. 78: 1-10 (1991).
Jarrett R F, Gallagher A, Jones D B, et al.. Detection of Epstein-Barr virus genomes in Hodgkin鈥檚 disease: Relation to age. Journal of Clinical
Pathology. 44: 844-848 (1991).
Pallesen G, Hamilton-Dutoit S J, Rowe M, et al.. Expression of Epstein-Barr (EBV) latent gene products in tumor cells of Hodgkin鈥檚 disease. Lancet.
337: 320-322 (1991).
Haribuchi Y, Yamanaka N, Katura A, et al.. Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal medline granuloma. Lancet. 335: 128-
130 (1990).
Young L, Alfieri C, Hennesy K, et al.. Expression of Epstein-Barr virus transformation-associated genes in tissue of patients with EBV lymphoprolifera-
tive disease. New England Journal of Medicine. 321: 1080-1085 (1989).
Fahraeus R, Li-Fu H, Ernberg I, et al.. Expression of the Epstein-Barr virus genome in nasopharyngeal carcinoma. International Journal of Cancer. 42:
329-338 (1988).
Rowe M, Evans H S, Young L S, et al.. Monoclonal antibodies to the latent membrane protein of Epstein-Barr virus reveal heterogeneity of the protein
and inducible expression in virus-transformed cells. Journal of General Virology. 68: 1575-1586 (1987).
VP-E609 is recommended FOR PROFESSIONAL AND RESEARCH USE ONLY. 7/04
Vector Laboratories, Inc., 30 Ingold Road, Burlingame, CA 94010 U.S.A.
Tel: (650)697-3600 鈥? Fax: (650)697-0339 鈥? Email: vector@vectorlabs.com 鈥? Web site: www.vectorlabs.com
|